Market Currents
Watson Pharmaceuticals (WPI -0.25%) sues the FDA for "improperly" denying the company's shared...
-
Wednesday, August 15, 2012, 9:55 AM ETWatson Pharmaceuticals (WPI -0.25%) sues the FDA for "improperly" denying the company's shared exclusivity for a generic version of Type 2 diabetes drug Actos despite the firm following the agency's directions. As a result of the FDA's decision, Watson's abbreviated new drug application (ANDA) could be delayed for up to six months.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
